(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

AS the new life-saving Respiratory Syncytial Virus (RSV) vaccination programme aimed at protecting newborns and older adults ...

Since the pandemic, health officials have approved new vaccines to help Americans combat severe symptoms from COVID-19, respiratory syncytial virus, or RSV, and influenza. Experts urge eligible ...

The good news is that even as cases rise and will likely continue to, new as well as tried and true vaccines are available to target COVID-19, influenza and respiratory syncytial virus ...

The NHS has started vaccinating pregnant women and older people against a respiratory virus that can make some people seriously ill. Officials suggest the respiratory syncytial virus (RSV ...

The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...

It can also help them find vaccines for respiratory illnesses like COVID, flu, respiratory syncytial virus (RSV) and pneumonia. "These are conditions that consumers engage in deeply," Pfizer Chief ...

“Make a plan now for you and your family to get both updated flu and COVID vaccines this fall, ahead of the respiratory virus season.” Here’s what to know about the vaccines available to protect ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...